COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 535: Articles 5341-5350  | Next

Amplification and extraction free quantitative detection of viral nucleic acids and single-base mismatches using magnetic signal amplification circuit
Roesch, E. L., Sack, R., Chowdhury, M. S., Wolgast, F., Schilling, M., Viereck, T., Lak, A.
10.1101/2022.12.24.521858 — Posted: 2022-12-26
In Vitro Inhibition of SARS-CoV-2 Infection by Bromhexine hydrochloride
Martins, R., Ferreira, I., Jorge, D. M., Almeida, L., Souza, J. d. P., Pontelli, M. C., Castro, I. A., Melquiades, T., Mendes Viana, R. M., Zamboni, D. S., Marcato, P., Arruda, E.
10.1101/2022.12.23.521817 — Posted: 2022-12-26
Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16
Wang, H., Rizvi, S. R. A., Dong, D., Lou, J., Wang, Q., Sopipong, W., Su, Y., Najar, F., Agarwal, P., Kozielski, F. G., Haider, S.
10.1101/2022.12.23.521761 — Posted: 2022-12-26
A large-scale serological survey in pets from October 2020 through June 2021 in France shows significantly higher exposure to SARS-CoV-2 in cats
Fritz, M., Elguero, E., Becquart, P., de Riols de Fonclare, D., Garcia, D., Beurlet, S., Denolly, S., Boson, B., Rosolen, S. G., Cosset, F.-L., Briend-Marchal, A., Legros, V., Leroy, E. M.
10.1101/2022.12.23.521567 — Posted: 2022-12-26
Risk of Suicide Attempts and Self-Directed Violence after SARS-CoV-2 Infection: Outcomes from an Emulated Trial of a Nationwide Observational Matched Cohort of US Veterans
Hynes, D. M., Niederhausen, M., Chen, J., Shahoumian, T., Rowneki, M., Hickok, A., Shepherd-Banigan, M., Hawkins, E. J., Naylor, J., Teo, A. R., Govier, D. J., Berry, K., McCready, H. D., Osborne, T. F., Wong, E. S., Hebert, P. L., Smith, V. A., Bowling, C. B., Boyko, E. J., Ioannou, G. N., Iwashyna, T. J., Maciejewski, M. L., O'Hare, A. M., Viglianti, E. M., Bohnert, A.
10.1101/2022.12.23.22283902 — Posted: 2022-12-26
EFFECTIVENESS OF CASIRIVIMAB-IMDEVIMAB AND SOTROVIMAB MONOCLONAL ANTIBODY TREATMENT AMONG HIGH-RISK PATIENTS WITH SARS-CoV-2 INFECTION: A REAL-WORLD EXPERIENCE
Tanriover, B., Gungor, A. B., Al-Obaidi, M., Thajudeen, B., Wong, R., Mansour, I., Zangeneh, T., Johnson, K., Low, N., Alam, R., Gonzalez, E., Sandikci, B., Muruganpandian, S., Gupta, G., Bedrick, E., Saridogan, T., Mendoza, K.
10.1101/2022.12.23.22283921 — Posted: 2022-12-26
Comparison of multiple whole-genome and Spike-only sequencing protocols for estimating variant frequencies via wastewater-based epidemiology
Winder, L. A., Parsons, P., Horsburgh, G., Maher, K., Hipperson, H., Wierzbicki, C., Jeffries, A. R., Brown, M. R., Fairbrother-Browne, A., Denise, H., Khalifa, M. S., Bassano, I., van Aerle, R., Williams, R., Farcas, K., Paterson, S., Blackwell, P. G., Burke, T.
10.1101/2022.12.22.22283855 — Posted: 2022-12-26
Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic
Bose Brill, S., Hirabayashi, K., Pajor, N. M., Rao, S., Mejias, A., Jhaveri, R., Forrest, C. B., Bailey, C., Christakis, D. A., Thacker, D., Lorman, V., Hanley, P. C., Patel, P., Cogen, J., Block, J., Prahalad, P., Lee, G.
10.1101/2022.12.23.22283868 — Posted: 2022-12-26
US Public Opinion as to Whether "The Pandemic is Over," September to October 2022
Czeisler, M. E., Weaver, M. D., Lane, R. I., Rajaratnam, S. M., Howard, M. E., Czeisler, C. A.
10.1101/2022.12.23.22283899 — Posted: 2022-12-26
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
Pisanic, N., Antar, A. A. R., Kruczynski, K. L., Gregory Rivera, M., Dhakal, S., Spicer, K., Randad, P. R., Pekosz, A., Klein, S. L., Betenbaugh, M. J., Detrick, B., Clarke, W., Thomas, D. L., Manabe, Y. C., Heaney, C. D.
10.1101/2022.12.22.22283858 — Posted: 2022-12-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).